Technology news and Jobs arrow Science arrow Deadly mutated breast cancer gene discovered
Deadly mutated breast cancer gene discovered E-mail
by William Atkins   
Thursday, 08 January 2009


Their paper entitled “MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer.”

Besides Drs. Chong, Kang, and Yang, the other researchers contributing to the study and paper are  Michael Reiss, Guohong Hu, Yong Wei, Mario A. Blanco, Feng Li,  Jessie L.-S. Au,  and Bruce G. Haffty,

Dr. Yang is now with the Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong Province, China

They state in the abstract to their paper, “Targeted therapy for metastatic diseases relies on the identification of functionally important metastasis genes from a large number of random genetic alterations.”

A computational algorithm (large database) was used to map alterations in recurrent genes that were thought to be related to the diagnosis of breast cancer and, in many cases, to a poor prognosis with the cancer.

From this analysis, 8q22 genomic gain was identified. It was found that 8q22 increases the chance of the metastasis of the gene metadherin (MTDH).

The 8q22 genomic gain was then validated with 250 samples of breast tumors as being present in over 40% of breast cancers and, when present, resulting in poor medical outcomes for the breast cancer patients.

Page three concludes.



 
< Next story in category   Previous story in the category >
iTWire user statistics Visitors last 30 days
694,279
Subscribers 15,210
#1 independent technology news advertise here
  •   *  
  • Search
  • AdvSeach
  • Login
  • Events
  • FreeStuff

- Advertisement -

Featured Whitepapers

Follow iTWire on Twitter

About iTWire

iTWire is all about technology news, information, jobs and community for the IT and telecommunications industry professional. Subscribe to our free ICT daily newsletter